Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT. [electronic resource]
Producer: 20110531Description: 1710-8 p. digitalISSN:- 1476-5365
- Adolescent
- Adult
- Aged
- Amphotericin B -- therapeutic use
- Antifungal Agents -- therapeutic use
- Aspergillosis -- drug therapy
- Aspergillus -- genetics
- Candida -- genetics
- Candidiasis -- drug therapy
- Child
- Female
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Male
- Middle Aged
- Mycoses -- drug therapy
- Polymerase Chain Reaction -- methods
- Prospective Studies
- Risk Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.